brv-pv
Trade name: Rotasil
Vaccineexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Jun 1, 2014 (NCT02145000)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- RotavirusImmunity, active
Rotavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- brv-pv
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02584816 | Phase 3 | Nov 1, 2015 | PATH, Serum Institute of India Pvt. Ltd. |
| NCT02145000 | Phase 3 | Jun 1, 2014 | Epicentre, Government of Niger, Medecins Sans Frontieres, Serum Institute of India Pvt. Ltd., University of Cincinnati |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Serum Institute of India Pvt. Ltd. | For profit | 2 | 1 | 1 | 2014 |
| Epicentre | For profit | 1 | 1 | 1 | 2014 |
| Government of Niger | Government | 1 | 0 | 1 | 2014 |
| Medecins Sans Frontieres | Academic/Hospital | 1 | 0 | 1 | 2014 |
| PATH | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Cincinnati | Academic/Hospital | 1 | 0 | 1 | 2014 |
6 organizations
Page 1 / 1